Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modifying toxicokinetics with antidotes

F J Baud1, S W Borron, C Bismuth

  • 1Hôpital Fernand Widal, Université Paris VII, France.

Toxicology Letters
|December 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LC-MS/MS method for quantification of baclofen in hair: A useful tool to assess compliance in alcohol dependent patients?

Drug testing and analysis·2017
Same author

Toxicodynetics in nordiazepam and oxazepam overdoses.

Annales pharmaceutiques francaises·2017
Same author

Toxicodynetics: A new discipline in clinical toxicology.

Annales pharmaceutiques francaises·2016
Same author

Early digoxin-specific antibody fragments for treating patients at risk of life-threatening digoxin toxicity.

Clinical toxicology (Philadelphia, Pa.)·2014
Same author

Comparison of radiographic measurements of the patellar tendon-tibial plateau angle with anatomical measurements in dogs. Validity of the common tangent and tibial plateau methods.

Veterinary and comparative orthopaedics and traumatology : V.C.O.T·2014
Same author

Predictive factors for extended-spectrum beta-lactamase producing Enterobacteriaceae causing infection among intensive care unit patients with prior colonization.

Infection·2014
Same journal

hERG Channel Blockade and Additive Interactions of Magnolol and Honokiol from Magnolia Species.

Toxicology letters·2026
Same journal

Evaluation of dose-dependent hematotoxic effects of celastrol on human blood cells in vitro.

Toxicology letters·2026
Same journal

Environmental pharmaceutical and antibiotic mixtures: An exposomics-guided framework for mechanistic toxicology.

Toxicology letters·2026
Same journal

Size- and morphology-dependent cytotoxicity of metal-organic frameworks: Deciphering the structure-toxicity relationship.

Toxicology letters·2026
Same journal

Steroidogenesis suppression in H295R cells by 1,3-disubstituted ureas: A potential off-target effect of some sEH inhibitors.

Toxicology letters·2026
Same journal

Signaling pathways in tobacco smoking-induced cervical carcinogenesis: Beyond HPV-mediated activation.

Toxicology letters·2026
See all related articles

Antidotes can alter how the body processes toxins (toxicokinetics) through five key mechanisms. Ultimately, the clinical effectiveness of any antidote is the most crucial measure of its success.

Area of Science:

  • Toxicology and Pharmacology
  • Clinical Medicine

Background:

  • Understanding toxicokinetics is crucial for developing effective antidote therapies.
  • Antidotes can influence the absorption, distribution, metabolism, and excretion of toxic substances.
  • Five primary mechanisms by which antidotes modify toxicokinetics have been identified.

Purpose of the Study:

  • To elucidate the five distinct mechanisms through which antidotes can modulate toxicokinetics.
  • To emphasize that modifying toxicokinetics is a means to an end, not the therapeutic goal itself.
  • To highlight the paramount importance of clinical outcomes in evaluating antidote efficacy.

Main Methods:

  • Review and categorization of known antidote mechanisms affecting toxicokinetics.
  • Analysis of how each mechanism impacts toxin bioavailability, distribution, elimination, and metabolism.

Related Experiment Videos

  • Emphasis on the clinical evaluation framework for antidotes.

    • Main Results:

    • Identified five key approaches: decreased bioavailability, cellular redistribution, enhanced elimination, slowed activation, and accelerated deactivation.
    • Demonstrated that understanding these mechanisms is essential but secondary to clinical results.
    • Stressed that the ultimate therapeutic success is determined by clinical evaluation.

    Conclusions:

    • Antidotes exert their effects by altering toxicokinetics via five main pathways.
    • The manipulation of toxicokinetics by antidotes should always be viewed within the context of achieving clinical benefit.
    • Clinical efficacy remains the definitive criterion for assessing the value of an antidote.